Abbott on Wednesday launched PediaSure SideKicks Clear, a clear nutritional beverage that helps balance out the diet of picky eaters who may be missing nutrients.

AstraZeneca has launched a new drug for treating high blood pressure, the company said Thursday.

Green Giant has introduced a new line of canned corn.

The results of CVS Caremark’s study, which found that its Pharmacy Advisor program increased medication adherence rates and physician initiation of prescriptions, is important as it further underscores the benefits of the program, and those benefits are bound to becomes even greater as the retailer gears up for the next generation of the clinical program.

National Bio+Green Sciences has created HandSan, which is positioned as the first-ever alcohol-free, organic hand cleanser made solely from purified water and vitamins with no artificial preservatives.

CVS Caremark is expanding its Pharmacy Advisor program to now include chronic cardiovascular care, a pharmacy-based approach to managing one of the most prevalent and expensive chronic illnesses.

PakSense has launched a new label that monitors time and temperature of such perishable items as food, vaccines, pharmaceuticals and biologics during distribution and storage.

Brynwood Partners VI L.P. has announced that High Ridge Brands, its portfolio company and owner of the North American Zest personal cleansing franchise, has signed a purchase agreement with Unilever to acquire the Alberto VO5 brand and marketing rights in the United States and Puerto Rico; as well as the rights to the Rave brand and marketing rights worldwide.

Purdue Pharma has launched a new website designed to combat abuse of prescription drugs, the company said Wednesday.

Greater consumer awareness of the dangers of the sun’s harmful rays and greater product innovation are spelling growth in the sun care market. And, as the industry wades through the recently issued regulations by the Food and Drug Administration, new innovative products for both children and adults hit the pipeline, which is likely to mean further growth.

The FDA has approved a new treatment for Type 2 diabetes, the agency said. The FDA announced the approval of Tradjenta (linagliptin) made by Indianapolis-based Eli Lilly and German drug maker Boehringer Ingelheim.